Planted Foods, a spin-off of the Swiss Federal Institute of Technology (ETH) Zurich and leading producer of sustainable and plant-based meat alternatives, has successfully closed a series B financing round in the amount of CHF 70
Swiss Life has successfully placed a senior bond in the amount of EUR 700 million maturing in 2029 with a coupon of 3.25% last 23th August 2022. The bond was placed with investors in the European market. The funds
Homburger has acted as counsel to Dätwyler Holding and Datwyler Parco Holdings in connection with a Swiss law governed USD 175 m credit facility arranged by UBS Switzerland for the purpose of refinancing certain indebtedness
Niederer Kraft Frey has acted as Swiss counsel to L Catterton on its investment in Planted Foods as part of the company’s Series B financing round. With approximately USD 33 billion of equity capital across
Infront has signed an agreement for the acquisition of Assetmax. The Swiss company is a service provider for independent asset managers, family offices and banks developing software for integrated multi-custody portfolio management, client relationship management,
Msg systems, a provider of intelligent IT and industry solutions, has announced the acquisition of the IT consulting company baeriswyl tschanz & partner. The IT and consulting company msg now takes over baeriswyl tschanz &
Intershop has sold the development property “AuPark” in Wädenswil to Swiss Life last19 August 2022 for a purchase price of CHF 190 million. A development with five residential and commercial buildings and around 230 apartments is planned
Clariant, a focused, sustainable and innovative specialty chemicals company, has successfully priced its first green bond on 24 August 2022. The CHF 175 million Green Bond has a coupon of 2.717 % and a 5 years term or maturity in 2027. UBS
In early 2021, ComCo opened an investigation into Mastercard for possible obstruction of SIX’s National Cash Scheme (NCS) and at the same time issued injunctions. Due to a complaint by Mastercard, the injunctions have not
Wenger Vieli has acted as legal advisor to Xeltis, a clinical-stage company developing medical devices enabling cardiovascular restoration, on securing EUR 15 million in equity and license fees from the lead investor as cornerstone funding in
